TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT05509569 updates: 1. completion date: 2026-05-29 → 2026-07-17 2. primary completion date: 2026-05-29 → 2026-07-17
Clinical trial NCT05509569 updates: 1. completion date: 2026-05-29 → 2026-07-17 2. primary completion date: 2026-05-29 → 2026-07-17
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical